Immunovaccine Announces 2016 Year-End Results
HALIFAX, NOVA SCOTIA--(Marketwired - Mar 30, 2017) - Immunovaccine Inc. ("Immunovaccine" or the "Corporation") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced its financial and operational …